ArticleImmunity, inflammation and disease2025

Identification of SETD4 as an Onco-Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers.

Yuyun Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.